BIOG.L Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 18:35):

Stats
Šios dienos apimtis	30 088.00
Vidutinė apimtis	71 713.00
Rinkos kapitalizacija	313.12M
EPS	£0 ( 2023-11-08 )
Kita pelno data	( £0 ) 2024-06-13
Last Dividend	£0.200 ( 2001-07-04 )
Next Dividend	£0 ( N/A )
P/E	-4.07
ATR14	£3.25 (0.35%)

Tūris Koreliacija

Ilgas: -0.15 (neutral)

Trumpas: -0.46 (neutral)

Signal:(54.174) Neutral

Biotech Growth Trust PLC Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
AFRN.L	0.952
LXI.L	0.928
LOK.L	0.925
VMUK.L	0.919
ALFA.L	0.917
JMI.L	0.917
BNKS.L	0.916
UTL.L	0.916
SDIP.L	0.914
NOG.L	0.911

10 Labiausiai neigiamai susiję koreliacijos
GLB.L	-0.947
UD04.L	-0.925
AMC.L	-0.918
UAI.L	-0.917
7DIG.L	-0.916
INX.L	-0.912
FCCN.L	-0.907
BVIC.L	-0.905
UNG.L	-0.905
TFG.L	-0.903

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Biotech Growth Trust PLC Koreliacija - Valiuta/Žaliavos

0.65
( moderate )

0.52
( weak )

0.50
( neutral )

0.51
( weak )

-0.24
( neutral )

-0.63
( weak negative )

Biotech Growth Trust PLC Finansinės ataskaitos

Annual	2022
Pajamos:	£-37.65M
Bruto pelnas:	£-37.65M (100.00 %)
EPS:	£-1.030

FY	2022
Pajamos:	£-37.65M
Bruto pelnas:	£-37.65M (100.00 %)
EPS:	£-1.030

FY	2022
Pajamos:	£-209.71M
Bruto pelnas:	£-209.71M (100.00 %)
EPS:	£-4.88

FY	2021
Pajamos:	£222.06M
Bruto pelnas:	£0.00 (0.00 %)
EPS:	£4.44

Financial Reports:

No articles found.

Biotech Growth Trust PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Biotech Growth Trust PLC Dividend Information - No Dividend Player

Dividend Sustainability Score: 2.02 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	£0.600	1998-07-13
Last Dividend	£0.200	2001-07-04
Next Dividend	£0	N/A
Payout Date	2001-07-30
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	£1.200	--
Avg. Dividend % Per Year	0.00%	--
Score	0.26	--
Div. Sustainability Score	2.02
Div.Growth Potential Score	0
Div. Directional Score	0.0842	--

Next Divdend (Est)
(2025-01-20)

£0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

0.26

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
1998	£0.600	0.62%
1999	£0.400	0.57%
2000	£0	0.00%
2001	£0.200	0.10%
2002	£0	0.00%
2003	£0	0.00%
2004	£0	0.00%
2005	£0	0.00%
2006	£0	0.00%
2007	£0	0.00%
2008	£0	0.00%
2009	£0	0.00%
2010	£0	0.00%
2011	£0	0.00%
2012	£0	0.00%
2013	£0	0.00%
2014	£0	0.00%
2015	£0	0.00%
2016	£0	0.00%
2017	£0	0.00%
2018	£0	0.00%
2019	£0	0.00%
2020	£0	0.00%
2021	£0	0.00%
2022	£0	0.00%
2023	£0	0.00%
2024	£0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
VMUK.L	Dividend Junior	2023-05-18	Annually	7	1.91%
MSLH.L	Dividend Knight	2023-10-19	Annually	33	1.56%
DOCS.L	Dividend Knight	2023-06-08	Semi-Annually	3	1.23%
SIGC.L	Dividend Junior	2023-09-14	Semi-Annually	3	0.82%
IMI.L	Dividend King	2023-08-10	Semi-Annually	32	1.40%
BOY.L	Dividend King	2023-10-05	Semi-Annually	32	1.77%
ORIT.L	Dividend Knight	2023-08-17	Quarterly	5	2.77%
FAIR.L	Dividend Royal	2023-08-24	Quarterly	9	7.08%
STS.L	Dividend King	2023-10-05	Quarterly	38	1.48%
JUST.L	Dividend Royal	2023-08-24	Annually	11	93.97%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	1.050	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	-0.299	1.200	-9.95	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.295	1.500	-4.39	-6.58	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.298	0.800	-3.51	-2.81	[1 - 3]
quickRatioTTM	0.298	0.800	-2.95	-2.36	[0.8 - 2.5]
cashRatioTTM	0.212	1.500	9.93	10.00	[0.2 - 2]
debtRatioTTM	0.0742	-1.500	8.76	-10.00	[0 - 0.6]
interestCoverageTTM	-176.03	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-0.159	2.00	-0.0530	-0.106	[0 - 30]
freeCashFlowPerShareTTM	-0.159	2.00	-0.0795	-0.159	[0 - 20]
debtEquityRatioTTM	0.0780	-1.500	9.69	-10.00	[0 - 2.5]
grossProfitMarginTTM	1.000	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	1.044	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.260	1.000	-2.56	-2.56	[0.2 - 2]
assetTurnoverTTM	-0.284	0.800	-5.23	-4.18	[0.5 - 2]
Total Score				2.02

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-3.81	1.000	-0.486	0	[1 - 100]
returnOnEquityTTM	-0.295	2.50	-2.82	-6.58	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.159	2.00	-0.0530	-0.159	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.159	2.00	-0.0530	-0.106	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-4.83	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0679	1.000	-0.803	0	[0.1 - 0.5]
Total Score				-1.856

Biotech Growth Trust PLC

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.